Dr. Matthieu Godin and his study team from the Clinique Saint Hilaire in Rouen, and Dr. Christophe Robin and his study team from the Clinique Convert in Bourg en Bresse, announce the successful inclusion of their first patient.
The study, sponsored by IHF GmbH and initiated by Prof. Dr. David M. Leistner and his study team from Charité Universitätsmedizin, reports further successes.
Under the direction of Dr. Matthieu Godin and his study team from the Clinique Saint Hilaire in Rouen, the first patient in France was successfully included. Shortly afterwards, Dr. Christophe Robin and his study team from the Clinique Convert in Bourg en Bresse announced the inclusion of their first patient.
We thank Dr. Godin and Dr. Robin and their teams for this important milestone in this prospective, multicenter, international observational study, which will enroll 2500 patients with coronary artery disease aged eighty years and older at up to 47 sites in Germany, Switzerland, Austria and France.
English 
German